In fact, a recent study reported that the microbiome in ALS mice helps restrain pro-inflammatory microglia, which is opposite to what happens in AD models [219]
The anti-inflammatory pathways modulated by GLP-1 receptor activation (NF-kB suppression, macrophage polarization, Treg enhancement) are largely distinct from the pathways targeted by: Methotrexate: Folate metabolism disruption, different anti-inflammatory pathway TNF inhibitors (adalimumab, etanercept): Direct TNF blockade, whereas GLP-1 reduces TNF production upstream IL-6 inhibitors (tocilizumab): Receptor-level blockade, while GLP-1 reduces IL-6 production JAK inhibitors (tofacitinib, baricitinib): Different signaling pathway entirely Corticosteroids: Broad immunosuppression, while GLP-1 is immunomodulatory This pathway complementarity is why additive benefit is biologically plausible
As a gut health dietitian, Im seeing more patients than ever who are taking GLP-1 medications like Ozempic, Wegovy, Mounjaro, and semaglutide for weight management and diabetes
Par la suite, on a pu identifier que lactivit de dtoxification cellulaire rsultait de lactivit enzymatique du GSH pouvant capter des radicaux libres
In September 1986 Mojsov and Habener's team published a joint article which drew very heavily on Mojsovs experiments and analysis
GLP-1 helps the pancreas release insulin to lower blood sugar, and it slows the rate at which our stomach empties, so we feel full for longer after a meal
